Meet
Michael Ciarametaro
Managing Director
Michael Ciarametaro provides strategic advice to life sciences clients on developing value and evidence strategy and navigating the Inflation Reduction Act (IRA), drug pricing, and payment reform
In recent projects, Mike has helped life sciences companies strategize and prepare for Medicare drug pricing negotiations under the IRA by evaluating value propositions for therapies, advising on how to improve those value propositions, identifying key opportunities to engage policymakers, and delivering strategic recommendations to clients.
He has also guided clients in creating value strategies relevant to the Institute for Clinical and Economic Reviews product evaluations.
Before joining Avalere, Mike served as vice president of research at the National Pharmaceutical Council, where he developed and managed a strategic research portfolio focused on innovation (e.g., its value and its relationship to payment reform), and drug market access challenges and solutions. He also held positions at WellPoint and NetRx, and at Evidera where he led financial analysis supporting the Pharmacy and Therapeutics committee and developing strategies for drug pricing and device market access.
Mike holds a bachelors degree in electrical engineering from the University of Virginia and a Master of Business Administration from George Mason University.